RESUMEN
We previously conducted a multicenter study enrolling 101 dialysis patients with hyperphosphatemia in which lanthanum carbonate (LC) was administered for 2 years. In this study, the administration has been continued for an additional year, and we have evaluated the long-term (a total of 3 years) effects of LC. The average serum phosphorus (P) level was 6.05 mg/dL at the start and decreased to 5.84 mg/dL after 3 years, but no significant differences were observed at both points. The average serum corrected calcium (Ca) level significantly reduced after 3 years (P < 0.001). As results of evaluating the achievement rates with the management target values of serum P, Ca and intact parathyroid hormone (PTH) stated in the Japanese guideline, the achievement rates increased after 3 years. From these results, LC is considered to be a useful P binder that can be used for long-term treatment of hyperphosphatemia, without causing a Ca load.
Asunto(s)
Hiperfosfatemia/tratamiento farmacológico , Fallo Renal Crónico/terapia , Lantano/uso terapéutico , Diálisis Renal/métodos , Anciano , Calcio/sangre , Femenino , Humanos , Hiperfosfatemia/etiología , Lantano/administración & dosificación , Masculino , Persona de Mediana Edad , Hormona Paratiroidea/sangre , Fósforo/sangre , Factores de Tiempo , Resultado del TratamientoRESUMEN
Long-term efficacy of lanthanum carbonate on hyperphosphatemia was examined in multicenter dialysis patients. Outcome and efficacy after 2 years was investigated in 101 patients who had undergone lanthanum carbonate administration. Thirty-three cases dropped out by the 2-year point; patients undergoing at least 2 years of administration totaled 68. Reasons for dropping out were as follows: improvement of hyperphosphatemia, nine cases; changing hospitals, seven cases; medical complications, five cases; digestive symptoms, four cases; poor compliance, four cases; parathyroidectomy, two cases; death, two cases. The mean dosage was increased from initial daily dosage of 744 mg to 1266 mg after 1 year, and to 1246 mg after 2 years. Serum phosphate concentration decreased significantly from the initial 6.15 mg to 5.57 mg/dL after 1 year, and to 5.45 mg/dL after 2 years. Although a lowering trend was observed in corrected calcium levels, the difference was not significant. Parathyroid hormone was unchanged. Achievement rate of Japanese Society for Dialysis Therapy (JSDT) management target values for both phosphorus and calcium improved from 32.7% to 50.0% after 1 year, and to 56.5% after 2 years. Lanthanum carbonate is useful as a therapeutic tool for hyperphosphatemia over long durations.
Asunto(s)
Hiperfosfatemia/tratamiento farmacológico , Fallo Renal Crónico/terapia , Lantano/uso terapéutico , Diálisis Renal/métodos , Anciano , Calcio/sangre , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Hiperfosfatemia/etiología , Lantano/administración & dosificación , Masculino , Persona de Mediana Edad , Hormona Paratiroidea/sangre , Fosfatos/sangre , Factores de Tiempo , Resultado del TratamientoRESUMEN
Loss of neurophysiological function in an anterior cruciate ligament (ACL)-deficient knee leads to irregularities in neuromuscular coordination, and any sudden change in circumstances is believed to contribute to deterioration in postural control. The aim of this study was to investigate differences between ACL-deficient patients and healthy subjects through examination of postural control in response to perturbation. Twelve patients awaiting ACL reconstruction were compared with 12 healthy athletes. Subjects were instructed to stand on an unstable board that was then tilted suddenly from behind. The stepping power and reaction time of subjects to this perturbation were measured through accelerometers attached to both the unstable board and the subjects' knees. In healthy athletes, stepping power was stronger on the tilted side than on the opposing side, while their step reaction, as part of anticipatory postural control, was faster on the opposing side than on the tilted side. In patients with ACL-deficient knees, the opposite was true; stepping power was no stronger on the tilted side, while their step reaction was no faster on the opposing side. In terms of postural control capability, both the affected and the healthy knee of ACL-deficient patients were impaired as a result of control patterns that differed from the usual model.
Asunto(s)
Inestabilidad de la Articulación/fisiopatología , Traumatismos de la Rodilla/fisiopatología , Articulación de la Rodilla/fisiopatología , Equilibrio Postural/fisiología , Adulto , Lesiones del Ligamento Cruzado Anterior , Femenino , Humanos , Masculino , Adulto JovenRESUMEN
If surgeons see the shaft of the extramedullary guide from lateral to the guide during preparation of the proximal tibia resection during total knee arthroplasty, the tibial component may be implanted in varus position in the frontal plane. In order to clarify the effect of the angle of the surgeons' sight relative to the sagittal plane and the posterior slope angle of the resected surface on varus position of the tibial component in the frontal plane, mathematical analysis was performed. Three-dimensional coordinate system was utilized so that the central axis of the tibial shaft on the Z-axis and the shaft of the guide were skew. The relationship between two lines was analyzed solving equations on three dimensional planes. When the posterior slope angle is 10 degrees, and if surgeons see the shaft of the guide 10 degrees, 20 degrees and 30 degrees lateral to the sagittal plane, and the shaft and the central axis of the tibial shaft would seem to be parallel, the true varus tilt angle of the shaft on the frontal plane is 1.8 degrees, 3.7 degrees and 5.8 degrees, respectively. The extramedullary guide should be seen straight in front of the guide.
Asunto(s)
Artroplastia de Reemplazo de Rodilla/métodos , Humanos , MatemáticaRESUMEN
Hyperosmolality in the renal medullary interstitium is generated by the renal countercurrent multiplication system, in which the medullary thick ascending limb (MAL) and the outer medullary collecting duct (OMCD) primarily participate. Since arginine vasopressin (AVP) regulates Na-K-ATPase activity directly via protein kinase A and indirectly via hyperosmolality, we investigated the acute and chronic effects of hyperosmolality on Na-K-ATPase and AVP-dependent cAMP generation in the MAL and OMCD. Microdissected MAL and OMCD from control and dehydrated rats were used for the measurement of Na-K-ATPase activity, mRNA expression of alpha-1, beta-1, and beta-2 subunits of Na-K-ATPase, and AVP-dependent cAMP generation. Na-K-ATPase activity in the MAL from dehydrated rats, as measured in isotonic medium, was higher than that of control rats. Moreover, incubation of samples in hypertonic medium (490 mOsm/kg H2O) further increased Na-K-ATPase activity. Dehydration increased alpha-1, beta-1, and beta-2 mRNA expression in the MAL without changing that in the OMCD. Western blot analysis revealed that in the outer medulla, the expression of beta-1, but not that of alpha-1 or beta-2, was stimulated by dehydration. Incubation of MAL or OMCD in hypertonic medium increased AVP-dependent cAMP generation. Higher levels of AVP-dependent cAMP were generated in the MAL from dehydrated rats than that of controls, although incubation in hypertonic medium did not lead to additional increases in AVP-dependent cAMP accumulation. In contrast, AVP-dependent cAMP generation in the OMCD was stimulated by dehydration, and was further stimulated by incubation in hypertonic medium. These findings demonstrate that Na-K-ATPase is upregulated short- and long-term hyperosmolality in the MAL, but not in OMCD.